JPMorgan Chase & Co. Issues Pessimistic Forecast for Ryan Specialty (NYSE:RYAN) Stock Price

Ryan Specialty (NYSE:RYAN) had its target price decreased by investment analysts at JPMorgan Chase & Co. from $63.00 to $56.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has an “underweight” rating on the stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 11.32% from the stock’s current price.

A number of other equities analysts have also issued reports on RYAN. Morgan Stanley set a $61.00 target price on shares of Ryan Specialty in a research report on Tuesday, December 16th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Ryan Specialty in a report on Wednesday, October 8th. Piper Sandler began coverage on Ryan Specialty in a research note on Thursday, November 20th. They issued a “neutral” rating and a $60.00 target price for the company. Barclays dropped their target price on Ryan Specialty from $70.00 to $65.00 and set an “overweight” rating for the company in a research report on Thursday, November 20th. Finally, Jefferies Financial Group initiated coverage on Ryan Specialty in a report on Monday, December 1st. They issued a “hold” rating and a $64.00 price target on the stock. One equities research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Ryan Specialty currently has an average rating of “Moderate Buy” and an average price target of $64.88.

Ryan Specialty Price Performance

Shares of RYAN stock opened at $50.30 on Wednesday. Ryan Specialty has a 52 week low of $50.08 and a 52 week high of $77.16. The stock has a market capitalization of $13.27 billion, a PE ratio of 109.36, a PEG ratio of 1.21 and a beta of 0.63. The company has a debt-to-equity ratio of 2.72, a quick ratio of 1.00 and a current ratio of 1.00. The stock’s fifty day moving average is $54.66 and its 200-day moving average is $57.30.

Ryan Specialty (NYSE:RYAN) last released its quarterly earnings results on Thursday, October 30th. The company reported $0.47 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.47. Ryan Specialty had a return on equity of 47.93% and a net margin of 7.61%.The business had revenue of $754.58 million during the quarter, compared to analysts’ expectations of $742.35 million. During the same period in the previous year, the business posted $0.41 earnings per share. The firm’s revenue for the quarter was up 24.8% compared to the same quarter last year. Equities research analysts expect that Ryan Specialty will post 2.29 EPS for the current fiscal year.

Insider Transactions at Ryan Specialty

In other news, CEO Timothy William Turner sold 129,570 shares of the business’s stock in a transaction dated Friday, December 12th. The stock was sold at an average price of $53.61, for a total transaction of $6,946,247.70. Following the completion of the transaction, the chief executive officer directly owned 12,553 shares in the company, valued at approximately $672,966.33. The trade was a 91.17% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 52.21% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Royal Bank of Canada increased its stake in Ryan Specialty by 10.6% in the first quarter. Royal Bank of Canada now owns 59,639 shares of the company’s stock valued at $4,406,000 after purchasing an additional 5,739 shares in the last quarter. AQR Capital Management LLC grew its holdings in shares of Ryan Specialty by 25.1% in the 1st quarter. AQR Capital Management LLC now owns 4,972 shares of the company’s stock valued at $367,000 after buying an additional 998 shares during the period. Goldman Sachs Group Inc. increased its position in shares of Ryan Specialty by 46.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 376,154 shares of the company’s stock valued at $27,787,000 after buying an additional 119,055 shares in the last quarter. United Services Automobile Association acquired a new stake in Ryan Specialty during the 1st quarter worth $490,000. Finally, Woodline Partners LP bought a new position in Ryan Specialty during the first quarter worth about $40,278,000. Institutional investors own 84.82% of the company’s stock.

Ryan Specialty Company Profile

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.